Our investigation further identified a direct interaction between ENO1 and TLR4 on GBM cells mediated by hydrogen bonding, consistent with prior reports of ENO1-TLR4 signaling in immune activation [27]. The gene discussed is ENO1; the disease is glioblastoma.